Advertisement

Lymph Nodes and Spleen

  • Xiaoqi LinEmail author
  • Juehua Gao
  • John K. S. S. Philip
  • Rosewell V. Mackey
  • Rehan Ali
  • Ahsun Riaz
Chapter

Abstract

The main indication for fine needle aspiration (FNA) and core needle biopsy (CNB) of lymph nodes or spleen is to rule out metastatic disease of either a known or unknown primary for staging or for local or diffuse lymphadenopathy in order to exclude lymphoma. We describe the radiographic features, cytomorphology of FNA or touch preparation of the cores, histology of CNB, immunohistochemical stains, flow cytometry, and molecular studies of common hematopoietic lesions and non-neoplastic lesions as well as metastatic malignancy.

Keywords

Lymph node Spleen Lymphoma Infection Inflammatory Cytomorphology Histology Radiology Immunohistochemistry 

References

  1. 1.
    Steinkamp HJ, Cornehl M, Hosten N, Pegios W, Vogl T, Felix R. Cervical lymphadenopathy: ratio of long- to short-axis diameter as a predictor of malignancy. Br J Radiol. 1995;68:266–70.PubMedCrossRefPubMedCentralGoogle Scholar
  2. 2.
    Kwon SY, Kim TK, Kim YS, Lee KY, Lee NJ, Seol HY. CT findings in Kikuchi disease: analysis of 96 cases. Am J Neuroradiol. 2004;25:1099–102.PubMedPubMedCentralGoogle Scholar
  3. 3.
    Tsujikawa T, Tsuchida T, Imamura Y, Kobayashi M, Asahi S, Shimizu K, et al. Kikuchi-Fujimoto disease: PET/CT assessment of a rare cause of cervical lymphadenopathy. Clin Nucl Med. 2011;36:661–4.PubMedCrossRefPubMedCentralGoogle Scholar
  4. 4.
    Khanna R, Sharma AD, Khanna S, Kumar M, Shukla RC. Usefulness of ultrasonography for the evaluation of cervical lymphadenopathy. World J Surg Oncol. 2011;9:29.PubMedPubMedCentralCrossRefGoogle Scholar
  5. 5.
    Choi YJ, Lee JH, Baek JH. Ultrasound elastography for evaluation of cervical lymph nodes. Ultrasonography. 2015;34:157–64.PubMedPubMedCentralCrossRefGoogle Scholar
  6. 6.
    Youk JH, Kim EK, Ko KH, Kim MJ. Sonographic features of axillary lymphadenopathy caused by Kikuchi disease. J Ultrasound Med. 2008;27:847–53.PubMedCrossRefPubMedCentralGoogle Scholar
  7. 7.
    Eisenmenger LB, Wiggins RH. Imaging of head and neck lymph nodes. Radiol Clin N Am. 2015;53:115–32.PubMedCrossRefPubMedCentralGoogle Scholar
  8. 8.
    Holzapfel K, Duetsch S, Fauser C, Eiber M, Rummeny EJ, Gaa J. Value of diffusion-weighted MR imaging in the differentiation between benign and malignant cervical lymph nodes. Eur J Radiol. 2009;72:381–7.PubMedCrossRefPubMedCentralGoogle Scholar
  9. 9.
    Si J, Huang S, Shi H, Liu Z, Hu Q, Wang G, et al. Usefulness of 3T diffusion-weighted MRI for discrimination of reactive and metastatic cervical lymph nodes in patients with oral squamous cell carcinoma: a pilot study. Dentomaxillofac Radiol. 2014;43:20130202.PubMedPubMedCentralCrossRefGoogle Scholar
  10. 10.
    Asano S. Granulomatous lymphadenitis. J Clin Exp Hematol. 2012;52:1–16.CrossRefGoogle Scholar
  11. 11.
    Armitage JO, Weisenburger DD. New approach to classifying non-Hodgkin’s lymphomas: clinical features of the major histologic subtypes. Non-Hodgkin’s Lymphoma Classification Project. J Clin Oncol. 1998;16:2780–95.PubMedCrossRefPubMedCentralGoogle Scholar
  12. 12.
    Hill BT, Weil AC, Kalaycio M, Cook JR. Pulmonary involvement by chronic lymphocytic leukemia/small lymphocytic lymphoma is a specific pathologic finding independent of inflammatory infiltration. Leuk Lymphoma. 2012;53:589–95.PubMedCrossRefPubMedCentralGoogle Scholar
  13. 13.
    Ghofrani M, Tantiwongkosi B, Smith AS, Wasdahl DA. Richter transformation of chronic lymphocytic leukemia presenting as a dural-based non-Hodgkin lymphoma mass. Am J Neuroradiol. 2007;28:318–20.PubMedPubMedCentralGoogle Scholar
  14. 14.
    Mauro FR, Chauvie S, Paoloni F, Biggi A, Cimino G, Rago A, et al. Diagnostic and prognostic role of PET/CT in patients with chronic lymphocytic leukemia and progressive disease. Leukemia. 2015;29:1360–5.PubMedCrossRefPubMedCentralGoogle Scholar
  15. 15.
    Hallek M, Cheson BD, Catovsky D, Caligaris-Cappio F, Dighiero G, Dohner H, et al. Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines. Blood. 2008;111:5446–56.PubMedPubMedCentralCrossRefGoogle Scholar
  16. 16.
    Project BTN-HsLC. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin’s lymphoma. The non-Hodgkin’s lymphoma classification project. Blood. 1997;89:3909–18.CrossRefGoogle Scholar
  17. 17.
    Hayashi D, Lee JC, Devenney-Cakir B, Zaim S, Ounadjela S, Solal-Celigny P, et al. Follicular non-Hodgkin’s lymphoma. Clin Radiol. 2010;65:408–20.PubMedCrossRefPubMedCentralGoogle Scholar
  18. 18.
    Barrington SF, Mikhaeel NG, Kostakoglu L, Meignan M, Hutchings M, Mueller SP, et al. Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group. J Clin Oncol. 2014;32:3048–58.PubMedPubMedCentralCrossRefGoogle Scholar
  19. 19.
    Rowley JD. Chromosome studies in the non-Hodgkin’s lymphomas: the role of the 14;18 translocation. J Clin Oncol. 1988;6:919–25.PubMedCrossRefPubMedCentralGoogle Scholar
  20. 20.
    Korsmeyer SJ. Bcl-2 initiates a new category of oncogenes: regulators of cell death. Blood. 1992;80:879–86.PubMedCrossRefPubMedCentralGoogle Scholar
  21. 21.
    Zucca E, Bertoni F, Roggero E, Cavalli F. The gastric marginal zone B-cell lymphoma of MALT type. Blood. 2000;96:410–9.PubMedCrossRefPubMedCentralGoogle Scholar
  22. 22.
    Hussell T, Isaacson PG, Crabtree JE, Spencer J. The response of cells from low-grade B-cell gastric lymphomas of mucosa-associated lymphoid tissue to Helicobacter pylori. Lancet. 1993;342:571–4.PubMedCrossRefPubMedCentralGoogle Scholar
  23. 23.
    Swerdlow S, Campo E, Harris NL, Jaffe E, Pileri S, Stein S, Thiele J, Vardiman J, editors. WHO classification of tumours of haematopoietic and lymphoid tissues. 4th ed. Lyon: International Agency for Research on Cancer (IARC); 2008.Google Scholar
  24. 24.
    Dierlamm J, Baens M, Stefanova-Ouzounova M, Hinz K, Wlodarska I, Maes B, et al. Detection of t(11;18)(q21;q21) by interphase fluorescence in situ hybridization using API2 and MLT specific probes. Blood. 2000;96:2215–8.PubMedCrossRefPubMedCentralGoogle Scholar
  25. 25.
    Mozos A, Royo C, Hartmann E, De Jong D, Baro C, Valera A, et al. SOX11 expression is highly specific for mantle cell lymphoma and identifies the cyclin D1-negative subtype. Haematologica. 2009;94:1555–62.PubMedPubMedCentralCrossRefGoogle Scholar
  26. 26.
    Zukerberg LR, Yang WI, Arnold A, Harris NL. Cyclin D1 expression in non-Hodgkin's lymphomas. Detection by immunohistochemistry. Am J Clin Pathol. 1995;103:756–60.PubMedCrossRefPubMedCentralGoogle Scholar
  27. 27.
    Ahuja AT, Ying M. Sonographic evaluation of cervical lymph nodes. Am J Roentgenol. 2005;184:1691–9.CrossRefGoogle Scholar
  28. 28.
    Tateishi U, Muller NL, Johkoh T, Onishi Y, Arai Y, Satake M, et al. Primary mediastinal lymphoma: characteristic features of the various histological subtypes on CT. J Comput Assist Tomogr. 2004;28:782–9.PubMedCrossRefPubMedCentralGoogle Scholar
  29. 29.
    Cronin CG, Swords R, Truong MT, Viswanathan C, Rohren E, Giles FJ, et al. Clinical utility of PET/CT in lymphoma. Am J Roentgenol. 2010;194:W91–103.CrossRefGoogle Scholar
  30. 30.
    Hans CP, Weisenburger DD, Greiner TC, Gascoyne RD, Delabie J, Ott G, et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood. 2004;103:275–82.CrossRefGoogle Scholar
  31. 31.
    Alizadeh AA, Eisen MB, Davis RE, Ma C, Lossos IS, Rosenwald A, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature. 2000;403:503–11.PubMedCrossRefPubMedCentralGoogle Scholar
  32. 32.
    Kramer MH, Hermans J, Wijburg E, Philippo K, Geelen E, van Krieken JH, et al. Clinical relevance of BCL2, BCL6, and MYC rearrangements in diffuse large B-cell lymphoma. Blood. 1998;92:3152–62.PubMedCrossRefPubMedCentralGoogle Scholar
  33. 33.
    Johnson NA, Savage KJ, Ludkovski O, Ben-Neriah S, Woods R, Steidl C, et al. Lymphomas with concurrent BCL2 and MYC translocations: the critical factors associated with survival. Blood. 2009;114:2273–9.PubMedPubMedCentralCrossRefGoogle Scholar
  34. 34.
    Vitolo U, Gaidano G, Botto B, Volpe G, Audisio E, Bertini M, et al. Rearrangements of bcl-6, bcl-2, c-myc and 6q deletion in B-diffuse large-cell lymphoma: clinical relevance in 71 patients. Ann Oncol. 1998;9:55–61.PubMedCrossRefGoogle Scholar
  35. 35.
    Rajkumar SV, Dimopoulos MA, Palumbo A, Blade J, Merlini G, Mateos MV, et al. International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol. 2014;15:e538–48.PubMedCrossRefGoogle Scholar
  36. 36.
    Treon SP, Xu L, Yang G, Zhou Y, Liu X, Cao Y, et al. MYD88 L265P somatic mutation in Waldenstrom’s macroglobulinemia. N Engl J Med. 2012;367:826–33.PubMedCrossRefGoogle Scholar
  37. 37.
    Varettoni M, Arcaini L, Zibellini S, Boveri E, Rattotti S, Riboni R, et al. Prevalence and clinical significance of the MYD88 (L265P) somatic mutation in Waldenstrom’s macroglobulinemia and related lymphoid neoplasms. Blood. 2013;121:2522–8.PubMedCrossRefGoogle Scholar
  38. 38.
    Vose J, Armitage J, Weisenburger D, International TCLP. International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes. J Clin Oncol. 2008;26:4124–30.PubMedCrossRefGoogle Scholar
  39. 39.
    Weisenburger DD, Savage KJ, Harris NL, Gascoyne RD, Jaffe ES, MacLennan KA, et al. Peripheral T-cell lymphoma, not otherwise specified: a report of 340 cases from the International Peripheral T-cell Lymphoma Project. Blood. 2011;117:3402–8.PubMedCrossRefGoogle Scholar
  40. 40.
    Murphy EL, Hanchard B, Figueroa JP, Gibbs WN, Lofters WS, Campbell M, et al. Modelling the risk of adult T-cell leukemia/lymphoma in persons infected with human T-lymphotropic virus type I. Int J Cancer. 1989;43:250–3.PubMedCrossRefPubMedCentralGoogle Scholar
  41. 41.
    Weiss LM, Jaffe ES, Liu XF, Chen YY, Shibata D, Medeiros LJ. Detection and localization of Epstein-Barr viral genomes in angioimmunoblastic lymphadenopathy and angioimmunoblastic lymphadenopathy-like lymphoma. Blood. 1992;79:1789–95.PubMedCrossRefPubMedCentralGoogle Scholar
  42. 42.
    Anagnostopoulos I, Hummel M, Finn T, Tiemann M, Korbjuhn P, Dimmler C, et al. Heterogeneous Epstein-Barr virus infection patterns in peripheral T-cell lymphoma of angioimmunoblastic lymphadenopathy type. Blood. 1992;80:1804–12.PubMedCrossRefPubMedCentralGoogle Scholar
  43. 43.
    Odejide O, Weigert O, Lane AA, Toscano D, Lunning MA, Kopp N, et al. A targeted mutational landscape of angioimmunoblastic T-cell lymphoma. Blood. 2014;123:129–36.CrossRefGoogle Scholar
  44. 44.
    Weiss LM, Strickler JG, Dorfman RF, Horning SJ, Warnke RA, Sklar J. Clonal T-cell populations in angioimmunoblastic lymphadenopathy and angioimmunoblastic lymphadenopathy-like lymphoma. Am J Pathol. 1986;122:392–7.PubMedPubMedCentralGoogle Scholar
  45. 45.
    Feller AC, Griesser H, Schilling CV, Wacker HH, Dallenbach F, Bartels H, et al. Clonal gene rearrangement patterns correlate with immunophenotype and clinical parameters in patients with angioimmunoblastic lymphadenopathy. Am J Pathol. 1988;133:549–56.PubMedPubMedCentralGoogle Scholar
  46. 46.
    Toma P, Granata C, Rossi A, Garaventa A. Multimodality imaging of Hodgkin disease and non-Hodgkin lymphomas in children. Radiographics. 2007;27:1335–54.PubMedCrossRefPubMedCentralGoogle Scholar
  47. 47.
    Bae YA, Lee KS. Cross-sectional evaluation of thoracic lymphoma. Radiol Clin N Am. 2008;46:253–64.. viiiPubMedCrossRefPubMedCentralGoogle Scholar
  48. 48.
    Jhanwar YS, Straus DJ. The role of PET in lymphoma. J Nucl Med. 2006;47:1326–34.PubMedPubMedCentralGoogle Scholar
  49. 49.
    Elsayes KM, Narra VR, Mukundan G, Lewis JS, Menias CO, Heiken JP. MR imaging of the spleen: spectrum of abnormalities. Radiographics. 2005;25:967–82.PubMedCrossRefPubMedCentralGoogle Scholar
  50. 50.
    Ahuja AT, Ying M, Ho SY, Antonio G, Lee YP, King AD, et al. Ultrasound of malignant cervical lymph nodes. Cancer Imaging. 2008;8:48–56.PubMedPubMedCentralCrossRefGoogle Scholar
  51. 51.
    Herndier BG, Sanchez HC, Chang KL, Chen YY, Weiss LM. High prevalence of Epstein-Barr virus in the Reed-Sternberg cells of HIV-associated Hodgkin’s disease. Am J Pathol. 1993;142:1073–9.PubMedPubMedCentralGoogle Scholar
  52. 52.
    Wang E, Hutchinson CB, Huang Q, Sebastian S, Rehder C, Kanaly A, et al. Histiocytic sarcoma arising in indolent small B-cell lymphoma: report of two cases with molecular/genetic evidence suggestive of a ‘transdifferentiation’ during the clonal evolution. Leuk Lymphoma. 2010;51:802–12.PubMedCrossRefPubMedCentralGoogle Scholar
  53. 53.
    Castro EC, Blazquez C, Boyd J, Correa H, de Chadarevian JP, Felgar RE, et al. Clinicopathologic features of histiocytic lesions following ALL, with a review of the literature. Pediatr Dev Pathol. 2010;13:225–37.PubMedCrossRefPubMedCentralGoogle Scholar
  54. 54.
    Arico M, Girschikofsky M, Genereau T, Klersy C, McClain K, Grois N, et al. Langerhans cell histiocytosis in adults. Report from the International Registry of the Histiocyte Society. Eur J Cancer. 2003;39:2341–8.PubMedCrossRefPubMedCentralGoogle Scholar
  55. 55.
    Gotz G, Fichter J. Langerhans’-cell histiocytosis in 58 adults. Eur J Med Res. 2004;9:510–4.PubMedPubMedCentralGoogle Scholar
  56. 56.
    Go H, Jeon YK, Huh J, Choi SJ, Choi YD, Cha HJ, et al. Frequent detection of BRAF (V600E) mutations in histiocytic and dendritic cell neoplasms. Histopathology. 2014;65:261–72.PubMedCrossRefPubMedCentralGoogle Scholar
  57. 57.
    Badalian-Very G, Vergilio JA, Degar BA, MacConaill LE, Brandner B, Calicchio ML, et al. Recurrent BRAF mutations in Langerhans cell histiocytosis. Blood. 2010;116:1919–23.PubMedPubMedCentralCrossRefGoogle Scholar
  58. 58.
    King DM. Imaging of metastatic melanoma. Cancer Imaging. 2006;6:204–8.PubMedCrossRefPubMedCentralGoogle Scholar
  59. 59.
    Fishman EK, Kuhlman JE, Schuchter LM, Miller JA, Magid D. CT of malignant melanoma in the chest, abdomen, and musculoskeletal system. Radiographics. 1990;10:603–20.PubMedCrossRefPubMedCentralGoogle Scholar
  60. 60.
    Patnana M, Bronstein Y, Szklaruk J, Bedi DG, Hwu WJ, Gershenwald JE, et al. Multimethod imaging, staging, and spectrum of manifestations of metastatic melanoma. Clin Radiol. 2011;66:224–36.PubMedCrossRefPubMedCentralGoogle Scholar
  61. 61.
    Strobel K, Dummer R, Husarik DB, Perez Lago M, Hany TF, Steinert HC. High-risk melanoma: accuracy of FDG PET/CT with added CT morphologic information for detection of metastases. Radiology. 2007;244:566–74.PubMedCrossRefPubMedCentralGoogle Scholar
  62. 62.
    Saiag P, Bernard M, Beauchet A, Bafounta ML, Bourgault-Villada I, Chagnon S. Ultrasonography using simple diagnostic criteria vs palpation for the detection of regional lymph node metastases of melanoma. Arch Dermatol. 2005;141:183–9.PubMedCrossRefPubMedCentralGoogle Scholar
  63. 63.
    Civardi GVD, Berte R, Giorgio A, Filice C, Caremani M, Caturelli E, et al. Ultrasound-guided fine needle biopsy of the spleen: high clinical efficacy and low risk in a multicenter Italian Study. Am J Hematol. 2001;67:93–9.PubMedCrossRefPubMedCentralGoogle Scholar
  64. 64.
    Benter T, Kluhs L, Teichgraber U. Sonography of the spleen. J Ultrasound Med. 2011;30:1281–93.PubMedCrossRefPubMedCentralGoogle Scholar
  65. 65.
    Rabushka LS, Kawashima A, Fishman EK. Imaging of the spleen: CT with supplemental MR examination. Radiographics. 1994;14:307–32.PubMedCrossRefPubMedCentralGoogle Scholar
  66. 66.
    Robertson F, Leander P, Ekberg O. Radiology of the spleen. Eur Radiol. 2001;11:80–95.PubMedCrossRefPubMedCentralGoogle Scholar
  67. 67.
    Raber EL, Haba J, Beck P. Splenic sarcoidosis: a case report and review of the imaging findings of multiple incidental splenic lesions as the initial presentation of sarcoidosis. Can J Gastroenterol. 2011;25:477–8.PubMedPubMedCentralCrossRefGoogle Scholar
  68. 68.
    Warshauer DM, Lee JK. Imaging manifestations of abdominal sarcoidosis. Am J Roentgenol. 2004;182:15–28.CrossRefGoogle Scholar
  69. 69.
    Koyama T, Ueda H, Togashi K, Umeoka S, Kataoka M, Nagai S. Radiologic manifestations of sarcoidosis in various organs. Radiographics. 2004;24:87–104.PubMedCrossRefPubMedCentralGoogle Scholar
  70. 70.
    Freeman JL, Jafri SZ, Roberts JL, Mezwa DG, Shirkhoda A. CT of congenital and acquired abnormalities of the spleen. Radiographics. 1993;13:597–610.PubMedCrossRefPubMedCentralGoogle Scholar
  71. 71.
    Caremani M, Occhini U, Caremani A, Tacconi D, Lapini L, Accorsi A, et al. Focal splenic lesions: US findings. J Ultrasound. 2013;16:65–74.PubMedPubMedCentralCrossRefGoogle Scholar
  72. 72.
    Urrutia M, Mergo PJ, Ros LH, Torres GM, Ros PR. Cystic masses of the spleen: radiologic-pathologic correlation. Radiographics. 1996;16:107–29.PubMedCrossRefPubMedCentralGoogle Scholar
  73. 73.
    Ishida H, Konno K, Ishida J, Naganuma H, Komatsuda T, Sato M, et al. Splenic lymphoma: differentiation from splenic cyst with ultrasonography. Abdom Imaging. 2001;26:529–32.PubMedCrossRefPubMedCentralGoogle Scholar
  74. 74.
    von Herbay A, Barreiros AP, Ignee A, Westendorff J, Gregor M, Galle PR, et al. Contrast-enhanced ultrasonography with SonoVue: differentiation between benign and malignant lesions of the spleen. J Ultrasound Med. 2009;28:421–34.CrossRefGoogle Scholar
  75. 75.
    Gorg C. The forgotten organ: contrast enhanced sonography of the spleen. Eur J Radiol. 2007;64:189–201.PubMedCrossRefPubMedCentralGoogle Scholar
  76. 76.
    Thipphavong S, Duigenan S, Schindera ST, Gee MS, Philips S. Nonneoplastic, benign, and malignant splenic diseases: cross-sectional imaging findings and rare disease entities. Am J Roentgenol. 2014;203:315–22.CrossRefGoogle Scholar
  77. 77.
    Mateo M, Mollejo M, Villuendas R, Algara P, Sanchez-Beato M, Martinez P, et al. 7q31-32 allelic loss is a frequent finding in splenic marginal zone lymphoma. Am J Pathol. 1999;154:1583–9.PubMedPubMedCentralCrossRefGoogle Scholar
  78. 78.
    Tiacci E, Trifonov V, Schiavoni G, Holmes A, Kern W, Martelli MP, et al. BRAF mutations in hairy-cell leukemia. N Engl J Med. 2011;364:2305–15.PubMedPubMedCentralCrossRefGoogle Scholar
  79. 79.
    Tiacci E, Schiavoni G, Forconi F, Santi A, Trentin L, Ambrosetti A, et al. Simple genetic diagnosis of hairy cell leukemia by sensitive detection of the BRAF-V600E mutation. Blood. 2012;119:192–5.PubMedCrossRefGoogle Scholar
  80. 80.
    Kotlyar DS, Osterman MT, Diamond RH, Porter D, Blonski WC, Wasik M, et al. A systematic review of factors that contribute to hepatosplenic T-cell lymphoma in patients with inflammatory bowel disease. Clin Gastroenterol Hepatol. 2011;9:36–41 e1.PubMedCrossRefPubMedCentralGoogle Scholar
  81. 81.
    Kristensen T, Vestergaard H, Bindslev-Jensen C, Moller MB, Broesby-Olsen S, Mastocytosis Centre OUH. Sensitive KIT D816V mutation analysis of blood as a diagnostic test in mastocytosis. Am J Hematol. 2014;89:493–8.PubMedCrossRefPubMedCentralGoogle Scholar
  82. 82.
    Arock M, Sotlar K, Akin C, Broesby-Olsen S, Hoermann G, Escribano L, et al. KIT mutation analysis in mast cell neoplasms: recommendations of the European Competence Network on Mastocytosis. Leukemia. 2015;29:1223–32.PubMedPubMedCentralCrossRefGoogle Scholar
  83. 83.
    Du J, Shen Q, Yin H, Zhou X, Wu B. Littoral cell angioma of the spleen: report of three cases and literature review. Int J Clin Exp Pathol. 2015;8:8516–20.PubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  • Xiaoqi Lin
    • 1
    Email author
  • Juehua Gao
    • 2
  • John K. S. S. Philip
    • 3
  • Rosewell V. Mackey
    • 4
  • Rehan Ali
    • 5
  • Ahsun Riaz
    • 6
  1. 1.Northwestern University, Feinberg School of Medicine, Northwestern Memorial HospitalChicagoUSA
  2. 2.Department of PathologyNorthwestern University, Feinberg School of MedicineChicagoUSA
  3. 3.Department of PathologyThomas Health SystemSouth CharlestonUSA
  4. 4.Department of RadiologyMcGaw Medical Center, Northwestern UniversityChicagoUSA
  5. 5.Department of RadiologySection of Vascular and Interventional Radiology, Northwestern UniversityChicagoUSA
  6. 6.Department of PathologyNorthwestern MedicineChicagoUSA

Personalised recommendations